Richard-Carpentier, G. (2023). Venetoclax-based lower-intensity regimens for acute myeloid leukemia: Clinical pearls for a new standard of care. Canadian Hematology Today, 2(1), 28–33. Retrieved from http://canadianhematologytoday.com/cht/article/view/2-1-5-richard-carpentier